Alnylam Pharmaceuticals (ALNY) Return on Capital Employed Growth (3y) (2013 - 2026)
Alnylam Pharmaceuticals (ALNY) Return on Capital Employed Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Alnylam Pharmaceuticals |
37.04 Bn |
34.03 Bn |
959.66 Mn |
4,853.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
4,853.00 |
| Dec 31, 2025 |
4,288.00 |
| Sep 30, 2025 |
3,813.00 |
| Jun 30, 2025 |
2,040.00 |
| Mar 31, 2025 |
1,916.00 |
| Dec 31, 2024 |
1,893.00 |
| Sep 30, 2024 |
1,808.00 |
| Jun 30, 2024 |
3,017.00 |
| Mar 31, 2024 |
2,227.00 |
| Dec 31, 2023 |
2,004.00 |
| Sep 30, 2023 |
1,932.00 |
| Jun 30, 2023 |
613.00 |
| Mar 31, 2023 |
1,988.00 |
| Dec 31, 2022 |
1,609.00 |
| Sep 30, 2022 |
812.00 |
| Jun 30, 2022 |
1,796.00 |
| Mar 31, 2022 |
2,921.00 |
| Dec 31, 2021 |
3,159.00 |
| Sep 30, 2021 |
2,144.00 |
| Jun 30, 2021 |
858.00 |
